EPISODE · Feb 25, 2023 · 55 MIN
Episode 16. ASH 2022 Leukemia and Myeloid Malignancies Recap
from Blood Cancer Talks · host Rajshekhar Chakraborty, Ashwin Kishtagari, and Edward Cliff
1. Phase III ASAP trialhttps://ash.confex.com/ash/2022/webprogram/Paper159962.html 2. Phase III Dauno-Double Trialhttps://ash.confex.com/ash/2022/webprogram/Paper157126.html 3. Reduced venetoclax exposure: https://ash.confex.com/ash/2022/webprogram/Paper165464.html 4. Menin Inhibitors in AML https://ash.confex.com/ash/2022/webprogram/Paper164849.htmlhttps://ash.confex.com/ash/2022/webprogram/Paper167412.html 5. Imetelstat in MDS: IMerge Phase 2https://ash.confex.com/ash/2022/webprogram/Paper169050.html 6. MOMENTUM: Momelotinibhttps://ash.confex.com/ash/2022/webprogram/Paper162783.htmlHow I manage anemia related to myelofibrosis and its treatment regimens https://link.springer.com/article/10.1007/s00277-023-05126-4
What this episode covers
1. Phase III ASAP trialhttps://ash.confex.com/ash/2022/webprogram/Paper159962.html 2. Phase III Dauno-Double Trialhttps://ash.confex.com/ash/2022/webprogram/Paper157126.html 3. Reduced venetoclax exposure: https://ash.confex.com/ash/2022/webprogram/Paper165464.html 4. Menin Inhibitors in AML https://ash.confex.com/ash/2022/webprogram/Paper164849.htmlhttps://ash.confex.com/ash/2022/webprogram/Paper167412.html 5. Imetelstat in MDS: IMerge Phase 2https://ash.confex.com/ash/2022/webprogram/Paper169050.html 6. MOMENTUM: Momelotinibhttps://ash.confex.com/ash/2022/webprogram/Paper162783.htmlHow I manage anemia related to myelofibrosis and its treatment regimens https://link.springer.com/article/10.1007/s00277-023-05126-4
NOW PLAYING
Episode 16. ASH 2022 Leukemia and Myeloid Malignancies Recap
No transcript for this episode yet
Similar Episodes
No similar episodes found.